Biotechnology – The New York Times

Latest Articles

Six years after the Affordable Care Act cleared the way for biosimilars, as the generic versions of biotechnology drugs are called, progress has been slow.

By ANDREW POLLACK

Scientists discovery that liquids are repelled from one another on a thin enough surface could have implications for materials science and bioengineering.

By JOANNA KLEIN

Among other applications, a new artificial stingray can teach scientists more about how the heart beats.

By STEPH YIN

A proposed law would make it unnecessarily difficult to check a label, by requiring the scanning of electronic codes in the store.

By THE EDITORIAL BOARD

As of Friday, nearly all food labels in the state must disclose when products include genetically engineered ingredients.

By STEPHANIE STROM

The worlds top scientists say opponents of genetically modified foods are standing in the way of nutrition for people around the world.

By NIRAJ CHOKSHI

The report from the National Academies of Sciences, Engineering and Medicine is not expected to end the highly polarized debate over the technology.

By ANDREW POLLACK

Bioengineered food products are safe. So why do we try to hide the facts about them?

By JASON KELLY

Efforts to expand use of biotechnology to crops other than corn, soybeans, cotton and canola have been hindered by opposition from consumer and environmental groups.

By ANDREW POLLACK

Federal officials have approved a cheaper version of Johnson & Johnsons blockbuster drug Remicade, a biotech medicine for inflammatory diseases.

General Mills said on Friday that it would start labeling all products that contain genetically modified ingredients to comply with a law set to go into effect in Vermont.

The salary, bonus and stock awards given to Fords chief executive, Mark Fields, jumped 17 percent in 2015.

The senators will consider whether the government should require labeling on foods containing genetically engineered ingredients, an issue that has split the food industry.

By JENNIFER STEINHAUER and STEPHANIE STROM

A diverse biotechnology company hopes its genetically engineered mosquitoes can help stop the spread of a devastating virus. But thats just a start.

By ANDREW POLLACK

States should be free to require the labeling of genetically modified food if they want to.

By THE EDITORIAL BOARD

Bioengineers at Rice University recently found that different drops from single fingerpricks on multiple subjects varied substantially.

By DONALD G. McNEIL Jr.

With the success of growing the body parts in a lab, bioengineers are taking a step toward creating replacement organs that can be transplanted into people.

By NICHOLAS ST. FLEUR

Marc Tessier-Lavigne, who will leave Rockefeller University to lead Stanford University, has also worked as an executive in the biotech industry,

The two biotech companies initial public offerings are testing the waters after a recent sell-off in biotech.

Businesses allow parents to leverage their wealth, contacts and the hope of investors to jump-start research into the diseases that afflict their children.

By PAUL SULLIVAN

Six years after the Affordable Care Act cleared the way for biosimilars, as the generic versions of biotechnology drugs are called, progress has been slow.

By ANDREW POLLACK

Scientists discovery that liquids are repelled from one another on a thin enough surface could have implications for materials science and bioengineering.

By JOANNA KLEIN

Among other applications, a new artificial stingray can teach scientists more about how the heart beats.

By STEPH YIN

A proposed law would make it unnecessarily difficult to check a label, by requiring the scanning of electronic codes in the store.

By THE EDITORIAL BOARD

As of Friday, nearly all food labels in the state must disclose when products include genetically engineered ingredients.

By STEPHANIE STROM

The worlds top scientists say opponents of genetically modified foods are standing in the way of nutrition for people around the world.

By NIRAJ CHOKSHI

The report from the National Academies of Sciences, Engineering and Medicine is not expected to end the highly polarized debate over the technology.

By ANDREW POLLACK

Bioengineered food products are safe. So why do we try to hide the facts about them?

By JASON KELLY

Efforts to expand use of biotechnology to crops other than corn, soybeans, cotton and canola have been hindered by opposition from consumer and environmental groups.

By ANDREW POLLACK

Federal officials have approved a cheaper version of Johnson & Johnsons blockbuster drug Remicade, a biotech medicine for inflammatory diseases.

General Mills said on Friday that it would start labeling all products that contain genetically modified ingredients to comply with a law set to go into effect in Vermont.

The salary, bonus and stock awards given to Fords chief executive, Mark Fields, jumped 17 percent in 2015.

The senators will consider whether the government should require labeling on foods containing genetically engineered ingredients, an issue that has split the food industry.

By JENNIFER STEINHAUER and STEPHANIE STROM

A diverse biotechnology company hopes its genetically engineered mosquitoes can help stop the spread of a devastating virus. But thats just a start.

By ANDREW POLLACK

States should be free to require the labeling of genetically modified food if they want to.

By THE EDITORIAL BOARD

Bioengineers at Rice University recently found that different drops from single fingerpricks on multiple subjects varied substantially.

By DONALD G. McNEIL Jr.

With the success of growing the body parts in a lab, bioengineers are taking a step toward creating replacement organs that can be transplanted into people.

By NICHOLAS ST. FLEUR

Marc Tessier-Lavigne, who will leave Rockefeller University to lead Stanford University, has also worked as an executive in the biotech industry,

The two biotech companies initial public offerings are testing the waters after a recent sell-off in biotech.

Businesses allow parents to leverage their wealth, contacts and the hope of investors to jump-start research into the diseases that afflict their children.

By PAUL SULLIVAN

Read more:
Biotechnology - The New York Times